Unicorn India Ventures Makes 6X Return on Partial Exit from Medtech Startup Sascan

Unicorn India Ventures Makes 6X Return on Partial Exit from Medtech Startup Sascan

Unicorn India Ventures (UIV), a deep tech-focused fund house, has announced a partial exit from Sascan Meditech, a neo-diagnostics startup. The fund had invested Rs 2 crore across two rounds starting in 2020, and this exit has generated a 6X return for UIV. Despite the partial exit, UIV continues to hold a significant stake in the company.

Founded in 2015 by Dr. Subhash Narayanan, Sascan Meditech aims to develop affordable healthcare products and solutions for cancer care using Biophotonics and allied technologies. The company's flagship products include OralScan and CerviScan, which are designed for non-invasive early cancer detection. Dr. Narayanan has expressed confidence in the company's ability to bring high-tech medical innovation to underprivileged populations in India and other developing countries.

Summary

Other news in business